Smithfield Foods could be one of the year's biggest U.S. initial public offerings, with the pork producer planning to raise ...

Chinese biotech Ascentage Pharma has taken the first US biotech initial public offering (IPO) of 2025 over the finish line, ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

CHINESE soda maker Dayao is gearing up for a Hong Kong initial public offering (IPO) as early as the second half of 2025, ...

Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

EcoCeres Inc., a producer of sustainable fuel backed by Bain Capital, is exploring an initial public offering that could ...

Chinese HR service provider 51job is set to go public in Hong Kong after its privatization in 2022, according to Chinese ...

Seven IPOs and one SPAC priced this past week, as more sizable issuers filed to go public in the US. Read more here.

A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.

The China-based drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is ...

Chinese soda maker Dayao is gearing up for a Hong Kong initial public offering (IPO) as early as the second half of the year, ...